Juan José Fernández-Miranda (Juan J Fernández-Miranda)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Peritoneal Dialysis

Randomized Controlled Trial

Bipolar Disorder

Top Venues

Journal of personalized medicine

Journal of clinical medicine

Neuropsychiatric disease and treatment

This page only lists publications with an associated author ORCID identifier.

Publications

Juan José Fernández-Miranda, Silvia Díaz-Fernández, Francisco Javier Cepeda-Piorno, Francisco López Muñoz
Long-Acting Injectable Second-Generation Antipsychotics in Seriously Ill Patients with Schizophrenia: Doses, Plasma Levels, and Treatment Outcomes. Biomedicines 12 (1) (2024)
Juan José Fernández-Miranda, Silvia Díaz-Fernández, Francisco Javier Cepeda-Piorno, Francisco López Muñoz
Long-Acting Injectable Second-Generation Antipsychotics in Seriously Ill Patients with Schizophrenia: Doses, Plasma Levels, and Treatment Outcomes. Biomedicines 12 (1) (2024)
Juan José Fernández-Miranda, Silvia Díaz Fernández
Plasmatic Levels and Response to Variable Doses of Monthly Aripiprazole and Three-Month Paliperidone in Patients with Severe Schizophrenia. Treatment Adherence, Effectiveness, Tolerability, and Safety. Neuropsychiatric disease and treatment 19 (2023)
Juan José Fernández-Miranda, Silvia Díaz Fernández, Francisco López Muñoz
The Use of Second-Generation Antipsychotics in Patients with Severe Schizophrenia in the Real World: The Role of the Route of Administration and Dosage-A 5-Year Follow-Up. Biomedicines 11 (1) (2022)
Juan José Fernández-Miranda, Silvia Díaz Fernández, Francisco López Muñoz
The Use of Second-Generation Antipsychotics in Patients with Severe Schizophrenia in the Real World: The Role of the Route of Administration and Dosage-A 5-Year Follow-Up. Biomedicines 11 (1) (2022)
Juan José Fernández-Miranda, Silvia Díaz-Fernández, Francisco López Muñoz
Effectiveness of More Personalized, Case-Managed, and Multicomponent Treatment for Patients with Severe Schizophrenia Compared to the Standard Treatment: A Ten-Year Follow-Up. Journal of personalized medicine 12 (7) (2022)
Juan José Fernández-Miranda, Silvia Díaz Fernández, Francisco López Muñoz
The Use of Second-Generation Antipsychotics in Patients with Severe Schizophrenia in the Real World: The Role of the Route of Administration and Dosage-A 5-Year Follow-Up. Biomedicines 11 (1) (2022)
Juan José Fernández-Miranda, Silvia Díaz Fernández, Domenico de Berardis, Francisco López Muñoz
Paliperidone Palmitate Every Three Months (PP3M) 2-Year Treatment Compliance, Effectiveness and Satisfaction Compared with Paliperidone Palmitate-Monthly (PP1M) in People with Severe Schizophrenia. Journal of clinical medicine 10 (7) (2021)